Singer, Susanne http://orcid.org/0000-0001-5784-7964
Sykiotis, Gerasimos http://orcid.org/0000-0002-9565-4941
Al-Ibraheem, Akram http://orcid.org/0000-0002-0978-4716
Pinto, Monica http://orcid.org/0000-0002-0823-4907
Iakovou, Ioannis
Østhus, Arild Andre http://orcid.org/0000-0002-0583-4106
Hammerlid, Eva http://orcid.org/0000-0002-1813-108X
Locati, Laura Deborah http://orcid.org/0000-0003-3315-2580
Gamper, Eva Maria http://orcid.org/0000-0002-1700-4054
Arraras, Juan Ignacio http://orcid.org/0000-0002-4415-2570
Jordan, Susan http://orcid.org/0000-0002-4566-1414
Buettner, Matthias http://orcid.org/0000-0002-7000-8257
Engesser, Deborah http://orcid.org/0000-0001-8377-1553
Taylor, Katherine http://orcid.org/0000-0003-0768-5789
Canotilho, Rita http://orcid.org/0000-0003-3914-0679
Ioannidis, Georgios http://orcid.org/0000-0003-2535-7279
Husson, Olga http://orcid.org/0000-0002-1387-8686
Gama, Ricardo Ribeiro http://orcid.org/0000-0003-4406-8958
Fanetti, Giuseppe http://orcid.org/0000-0002-9677-3176
Moss, Laura
Inhestern, Johanna http://orcid.org/0000-0003-4613-2810
Andry, Guy http://orcid.org/0000-0001-7410-6519
Rimmele, Harald
Kiyota, Naomi http://orcid.org/0000-0001-8021-6116
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer (002/2017)
Japan Agency for Medical Research and Development (21ck0106498h0003)
Article History
Received: 10 August 2023
Accepted: 23 November 2023
First Online: 16 December 2023
Compliance with ethical standards
:
: S.S. has received honoraria from Lilly for reviewing papers for their Quality of Life Award and from Eisei for advice in writing a paper, outside of the submitted work. N.K. reports honoraria from ONO PHARMACEUTICAL, Bristol Meyers Squibb, Merck Biopharma, Astra-Zeneca, Merck Sharp & Dohme, Eisai, Bayer and Chugai Pharmaceutical, all outside the submitted work. M.P. reports speaker fees from Meeting&Words and from Hinovia S.r.l., outside the submitted work. G.S. has received research support in the form of donations from Merck Sharp & Dohme, IBSA and Alpha-Sigma, which partially defrayed costs associated with recruiting patients in this study. M.B. has received speaker fees from Lilly and Takeda outside of the submitted work. All authors have a special interest in quality of life in thyroid cancer patients and survivors. The authors declare that they have no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
: Written informed consent was obtained from all individual participants included in the study.
: All procedures performed were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki Declaration and its later amendments of comparable ethical standards. All sites obtained ethical approval in accordance with regional and national requirements. Approval number from the principal investigator’s institution: 837.406.17 (11240).